secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001104659-25-050435
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 2025 Equity Incentive Plan authorizing 3.47M new shares
----------------------------------------------------------------------------

- Shareholders voted 20.3M for, 7.1M against to approve the 2025 Equity Incentive Plan.
- Plan authorizes 3,474,404 shares for issuance to employees, directors, and consultants.
- All eight director nominees elected; say-on-pay and auditor ratification also approved.
- Director compensation capped at $750k annually ($1M first year).
- Vesting minimum of one year for awards, except up to 5% of shares can have shorter vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465925050435/0001104659-25-050435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465925050435/tm2515549d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-050435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer